Keyphrases
Moderate to Severe
100%
Forced Expiratory Volume in 1 Second (FEV1)
100%
Tiotropium
100%
Severe COPD
100%
Fluticasone Propionate
100%
Salmeterol
100%
Lung Function
40%
Twice Daily
40%
Once-daily
40%
Health Status
40%
Adverse Events
40%
Albuterol
40%
Randomized Double-blind
20%
Improved Outcomes
20%
Placebo
20%
Efficacy Endpoint
20%
Mechanism of Action
20%
Acute Exacerbation of COPD (AECOPD)
20%
Cigarette Smoking
20%
No Significant Difference
20%
Treatment Group
20%
Smoking History
20%
Pack-years
20%
Maintenance Medication
20%
Lung Function Parameters
20%
Post-bronchodilator
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Fluticasone Propionate
100%
Salmeterol
100%
Health Status
33%
Adverse Event
33%
Salbutamol
33%
Cigarette Smoking
16%
Placebo
16%
Bronchodilating Agent
16%
Fluticasone
16%
Treatment Group
16%
Immunology and Microbiology
Forced Expiratory Volume
100%
Salmeterol
100%
Fluticasone Propionate
100%
Health Status
40%
Salbutamol
40%
Fluticasone/Salmeterol
20%
Bronchodilator
20%